Stryker (SYK) EBIT (2009 - 2026)

Stryker (SYK) has 18 years of EBIT data on file, last reported at $936.0 million in Q1 2026.

• Quarterly EBIT rose 11.83% year-over-year to $936.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 billion (up 40.35% YoY) and the FY2025 annual result came in at $4.9 billion, up 32.53% from the prior year.
• EBIT fell to $936.0 million in Q1 2026 per SYK's latest filing, from $1.8 billion in the prior quarter.
• Across five years, EBIT topped out at $1.8 billion in Q4 2025 and bottomed at $447.0 million in Q1 2022.
• The 5-year median for EBIT is $936.0 million (2026), against an average of $955.5 million.
• The widest annual swing landed in 2024, when EBIT sank 53.78%; it then surged 210.5% in 2025.
• Tracing SYK's EBIT over 5 years: stood at $814.0 million in 2022, then soared by 54.42% to $1.3 billion in 2023, then sank by 53.78% to $581.0 million in 2024, then surged by 210.5% to $1.8 billion in 2025, then tumbled by 48.12% to $936.0 million in 2026.
• Per Business Quant, the three latest SYK EBIT figures stand at $936.0 million (Q1 2026), $1.8 billion (Q4 2025), and $1.1 billion (Q3 2025).

Peer Comparison